Hemolytic uremic syndrome in adults

Area of Science:

• Nephrology
• Internal Medicine
• Hematology

Background:

• Hemolytic-uremic syndrome (HUS) is a serious condition primarily affecting children, but adult cases present unique clinical challenges.
• Understanding the long-term prognosis and potential complications in adults with HUS is crucial for effective patient management.

Purpose of the Study:

• To report the long-term clinical course and outcomes of 11 adult patients diagnosed with hemolytic-uremic syndrome (HUS).
• To evaluate the efficacy of heparin and antiplatelet therapy in the acute phase and assess long-term sequelae.

Main Methods:

• Retrospective analysis of 11 adult patients with HUS.
• Documentation of treatment regimens, including heparin and antiplatelet agents.
• Long-term follow-up to assess renal function, blood pressure, and survival.

Main Results:

• Ten of 11 patients required dialysis during the acute phase; one patient died within 38 days.
• Recovery from anuria occurred between 7 and 400 days for the surviving patients.
• At long-term follow-up (1-10 years), 4 of 8 patients showed renal failure, and 4 had normal renal function; 7 of 8 required antihypertensive therapy.

Conclusions:

• Recovery from prolonged anuria in adult HUS is possible, highlighting the importance of continued supportive care.
• Adults with HUS face risks of late-onset severe hypertension and progressive renal failure, necessitating vigilant long-term monitoring.
• Heparin and antiplatelet drugs appear beneficial in reversing acute renal failure in adult HUS, warranting further investigation.